First Light Asset Management, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
First Light Asset Management, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$40,107,391
+47.4%
1,125,032
+90.7%
3.81%
+78.6%
Q2 2023$27,214,993
+187.8%
589,963
+150.2%
2.13%
+150.6%
Q1 2023$9,454,658
-12.9%
235,777
+0.6%
0.85%
-15.6%
Q4 2022$10,855,073
-42.2%
234,299
-48.4%
1.01%
-47.0%
Q3 2022$18,792,000
-30.4%
453,794
+0.3%
1.90%
-39.4%
Q2 2022$26,994,000
-15.0%
452,470
+3.4%
3.14%
+12.1%
Q1 2022$31,772,000
-8.1%
437,512
+6.4%
2.80%
+13.1%
Q4 2021$34,587,000
-13.1%
411,313
-6.8%
2.48%
-5.5%
Q3 2021$39,788,000
+82.0%
441,159
+92.4%
2.62%
+99.9%
Q2 2021$21,859,000
-11.7%
229,246
+5.4%
1.31%
-20.2%
Q1 2021$24,760,000
-16.4%
217,459
+1.7%
1.64%
-25.0%
Q4 2020$29,608,000
+94.8%
213,887
+15.6%
2.19%
+40.6%
Q3 2020$15,203,000
-18.0%
184,970
-21.9%
1.56%
-27.9%
Q2 2020$18,535,000
+21.8%
236,958
-30.8%
2.16%
-16.9%
Q1 2020$15,222,000
+104.3%
342,603
+96.4%
2.60%
+173.0%
Q4 2019$7,450,000
-3.1%
174,437
-2.9%
0.95%
-18.1%
Q3 2019$7,686,000
-32.8%
179,659
-0.2%
1.16%
-26.8%
Q2 2019$11,431,000180,0171.59%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 727,426$25,932,7374.72%
RTW INVESTMENTS, LP 5,405,089$192,691,4234.07%
First Light Asset Management, LLC 1,125,032$40,107,3913.81%
CHI Advisors LLC 215,000$7,664,7503.04%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 250,052$8,914,3543.00%
SPHERA FUNDS MANAGEMENT LTD. 259,135$9,238,1631.68%
Rock Springs Capital Management LP 1,476,441$52,635,1221.41%
SUVRETTA CAPITAL MANAGEMENT, LLC 679,459$24,222,7131.31%
Privium Fund Management B.V. 115,241$4,108,3411.22%
SECTOR GAMMA AS 115,166$4,105,6681.05%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders